UPB: Upstream Bio, Inc. Common Stock Company Profile & Statistics

Upstream Bio, Inc. Common Stock Profile

About

Upstream Bio Inc. is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the only known antagonist currently in development which targets the receptor for thymic stromal lymphopoietin, a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases. Upstream Bio Inc. is based in WALTHAM, Mass.

Info & Links

CEO

E. Rand Sutherland

Headquarters

890 Winter Street, Suite 200
Waltham, MA 02451, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

Upstream Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

1.43B

Enterprise Value

1.36B

Enterprise Value/EBITDA(ttm)

-9.52

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

493.28

Price to Book(mrq)

3.64

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-4366.77%

Profit Margin(ttm)

-4394.78%

Return on Equity(ttm)

-28.71%

Return on Invested Capital(ttm)

-29.33%

Return on Assets(ttm)

-27.94%

Income Statement

Revenue(ttm)

2.80M

Revenue Per Share(ttm)

0.05

Gross Profit(ttm)

2.80M

EBITDA(ttm)³

-142.52M

Net Income Available to Common(ttm)

-122.77M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

52-Week Change

45.44%

S&P 500 52-Week Change

11.76%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

54.04M

Dividend Yield

0.00%

Float⁴

46.71M

% Held by Insiders

13.56%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

372.43M

Total Cash Per Share(mrq)

6.89

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

32.67%

Quick Ratio(mrq)

32.67%

Book Value Per Share(mrq)

7.01

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.90

Free Cash Flow(ytd)

-102.75M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

UPB

Upstream Bio, Inc. Common Stock